论文部分内容阅读
目的:分析头孢哌酮钠/舒巴坦钠治疗妇产科感染的临床疗效。方法:选择我院2010年1月至2012年7月收治的132例妇科门诊或者住院感染患者,并将其随机分为观察组和对照组,每组66例患者。观察组患者采用头孢哌酮钠/舒巴坦钠治疗,对照组患者采用阿莫西林/克拉维酸治疗,治疗7-15天后比较两组患者的临床效果。结果:治疗后,观察组患者的总有效率为96.96%,明显高于对照组患者,差异具有明显统计学意义(P<0.05)。两组患者的细菌清除率和不良反应的发生率基本相当,差异无明显统计学意义(P>0.05)。结论:头孢哌酮钠/舒巴坦钠治疗各种妇产科感染疗效显著,安全性高,值得临床推广应用。
Objective: To analyze the clinical efficacy of cefoperazone sodium / sulbactam sodium in obstetrics and gynecology infection. Methods: A total of 132 gynecological outpatients or hospitalized patients admitted to our hospital from January 2010 to July 2012 were selected and randomly divided into observation group and control group, with 66 patients in each group. Patients in the observation group were treated with cefoperazone sodium / sulbactam sodium, while patients in the control group were treated with amoxicillin / clavulanic acid. The clinical effects of the two groups were compared after 7-15 days of treatment. Results: After treatment, the total effective rate of the observation group was 96.96%, which was significantly higher than that of the control group, the difference was statistically significant (P <0.05). The rates of bacterial clearance and adverse reactions in both groups were basically the same, with no significant difference (P> 0.05). CONCLUSION: Cefoperazone sodium / sulbactam sodium is effective in treating various obstetrics and gynecology infections and has high safety. It is worthy of clinical application.